Micro-concentration Lipopolysaccharide as a Novel Stimulator of Megakaryocytopoiesis that Synergizes with IL-6 for Platelet Production

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Di ^a   Xie, Jun ^b   Wang, Xuejun ^a   Zou, Bingcheng ^a   Yu, Yin ^a   Jing, Tao ^a   Zhang, Songmei ^a   Zhang, Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; KANAMYCIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; THROMBOPOIETIN; TOLL LIKE RECEPTOR 4;

ANIMAL; BAGG ALBINO MOUSE; BLOOD; CFU COUNTING; CYTOLOGY; DRUG EFFECTS; GENETICS; MALE; MEGAKARYOCYTE; METABOLISM; PHOSPHORYLATION; POLYPLOIDY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD PLATELETS; COLONY-FORMING UNITS ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERLEUKIN-3; INTERLEUKIN-6; KANAMYCIN; LIPOPOLYSACCHARIDES; MALE; MEGAKARYOCYTES; MICE, INBRED BALB C; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET COUNT; POLYPLOIDY; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; THROMBOPOIESIS; THROMBOPOIETIN; TOLL-LIKE RECEPTOR 4;

EID: 84940856153     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13748     Document Type: Article

References (43)

1. Rietschel, E. T. et al. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216, 39-81 (1996).
2. O'Brien, A. D. et al. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol 124, 20-24 (1980).
3. Konecny, F. A. Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis. J Res Med Sci 15, 348-358 (2010).
4. Wang, J. E. et al. Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood. Shock 16, 178-182 (2001).
5. Dinarello, C. A. Proinflammatory cytokines. Chest 118, 503-508 (2000).
6. An, E., Ogata, K., Kuriya, S., Nomura, T. Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Exp Hematol 22, 149-156 (1994).
7. Williams, N., Bertoncello, I., Jackson, H., Arnold, J., Kavnoudias, H. The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production. Ciba Found Symp 167, 160-170 (1992).
8. Kafoury, R. M., Hernandez, J. M., Lasky, J. A., Toscano, W. A., Jr., Friedman, M. Activation of transcription factor IL-6 (NFIL-6) and nuclear factor-kappaB (NF-kappaB) by lipid ozonation products is crucial to interleukin-8 gene expression in human airway epithelial cells. Environ Toxicol 22, 159-168, doi: 10.1002/tox.20246 (2007).
9. Gainsford, T. et al. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Blood 95, 528-534 (2000).
10. Patel, S. R., Hartwig, J. H., Italiano, J. E., Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115, 3348-3354, doi: 10.1172/JCI26891 (2005).
11. Greenberg, S. M., Rosenthal, D. S., Greeley, T. A., Tantravahi, R., Handin, R. I. Characterization of a new megakaryocytic cell line: the Dami cell. Blood 72, 1968-1977 (1988).
12. Zimmet, J., Ravid, K. Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol 28, 3-16 (2000).
13. Ault, K. A., Knowles, C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 23, 996-1001 (1995).
14. Italiano, J. E., Jr., Mairuhu, A. T., Flaumenhaft, R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 17, 578-584, doi: 10.1097/MOH.0b013e32833e77ee (2010).
15. Zhiyi, H. et al. Secretion expression and activity assay of a novel fusion protein of thrombopoietin and interleukin-6 in Pichia pastoris. J Biochem 142, 17-24, doi: 10.1093/jb/mvm111 (2007).
16. Beaulieu, L. M., Freedman, J. E. The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb Res 125, 205-209, doi: 10.1016/j.thromres.2009.11.004 (2010).
17. Jayachandran, M. et al. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol (1985) 102, 429-433, doi: 10.1152/japplphysiol.01576.2005 (2007).
18. Gessani, S. et al. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J Immunol 151, 3758-3766 (1993).
19. Yang, S. et al. The effect of toll-like receptor 4 on macrophage cytokines during endotoxin induced uveitis. Int J Mol Sci 13, 7508-7520, doi: 10.3390/ijms13067508 (2012).
20. Espanol, I., Hernandez, A., Cortes, M., Mateo, J., Pujol-Moix, N. Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels. Haematologica 84, 312-316 (1999).
21. Andonegui, G. et al. Platelets express functional Toll-like receptor-4. Blood 106, 2417-2423, doi: 10.1182/blood-2005-03-0916 (2005).
22. Jayachandran, M., Miller, V. M., Brunn, G. J., Owen, W. G. Platelet response as a sentinel marker of toll-like receptor 4 activation in mice. Thrombosis Research 126, 414-417, doi: 10.1016/j.thromres.2009.05.005 (2010).
23. Bals, R. Lipopolysaccharide and the lung: a story of love and hate. Eur Respir J 25, 776-777, doi: 10.1183/09031936.05.00025405 (2005).
24. Ault, K. A. et al. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 98, 637-646 (1992).
25. Millot, G. A. et al. MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth. Exp Hematol 30, 166-175 (2002).
26. Wang, Q. et al. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling. The international journal of biochemistry & cell biology 45, 2852-2863, doi: 10.1016/j. biocel.2013.09.010 (2013).
27. Gyorfy, Z., Duda, E., Vizler, C. Interactions between LPS moieties and macrophage pattern recognition receptors. Vet Immunol Immunopathol 152, 28-36, doi: 10.1016/j.vetimm.2012.09.020 (2013).
28. Kobayashi, S. et al. Stretch-induced IL-6 secretion from endothelial cells requires NF-kappaB activation. Biochem Biophys Res Commun 308, 306-312 (2003).
29. Morrison, D. C., Bucklin, S. E. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis. Scand J Infect Dis Suppl 101, 3-8 (1996).
30. Bhatia, M., He, M., Zhang, H., Moochhala, S. Sepsis as a model of SIRS. Front Biosci (Landmark Ed) 14, 4703-4711 (2009).
31. Italiano, J. E. et al. Mechanisms and implications of platelet discoid shape. Blood 101, 4789-4796, doi: 10.1182/blood-2002-11-3491 (2003).
32. Baatout, S. Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol 73, 157-162 (1996).
33. Kienast, J., Schmitz, G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75, 116-121 (1990).
34. Li, Z., Yang, F., Dunn, S., Gross, A. K., Smyth, S. S. Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res 127, 184-188, doi: 10.1016/j.thromres.2010.10.010 (2011).
35. Corash, L. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis. Expert Rev Hematol 4, 509-525, doi: 10.1586/ehm.11.53 (2011).
36. Mantovani, A., Garlanda, C. Platelet-macrophage partnership in innate immunity and inflammation. Nat Immunol 14, 768-770, doi: 10.1038/ni.2666 (2013).
37. Trzeciak-Ryczek, A., Tokarz-Deptula, B., Deptula, W. Platelets-an important element of the immune system. Pol J Vet Sci 16, 407-413 (2013).
38. Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13, 463-469, doi: 10.1038/nm1565 (2007).
39. Sugimoto, M., Wakabayashi, Y., Hirose, S., Murphy, M. J., Jr. Megakaryocyte colony-stimulating factor and burst-promoting activity in LPS-treated mouse spleen cell-conditioned medium. Exp Cell Biol 56, 245-253 (1988).
40. Pang, L., Weiss, M. J., Poncz, M. Megakaryocyte biology and related disorders. J Clin Invest 115, 3332-3338, doi: 10.1172/JCI26720 (2005).
41. Plotnikov, A., Zehorai, E., Procaccia, S., Seger, R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813, 1619-1633, doi: 10.1016/j.bbamcr.2010.12.012 (2011).
42. Bunting, S. et al. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 90, 3423-3429 (1997).
43. de Sauvage, F. J. et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 183, 651-656 (1996).